Total stockholders’ equity (deficiency) (2,958,866) as of 4/30/2020 7,672,599 as of 7/31/2019
So one of the key components of uplisting for GNBT is positive shareholder’s equity of $5M+. We are now at -$2,938,866
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Building Wealth Through Dividend Stocks
Creating a portfolio filled with high-quality dividend-paying stocks is a smart way to secure passive income for the long term. The key is to focus on companies that not only offer attractive dividends today but also have a history of increasing those dividends over time. This strategy can help you avoid selling your shares for additional income during retirement. Moreover, studies indicate that stocks with a consistent track record of raising ... Continue Reading
Investors of Sunlight Financial Holdings Should Be AwareAttention all investors of Sunlight Financial Holdings, Inc. f/k/a Spartan Acquisition Corp. II (OTCMKTS: SUNLQ)! You may have encountered news about a significant development that could greatly affect your investment. A class action lawsuit has been initiated against Sunlight Financial, and it’s crucial for you to be informed about what this means for you and your stakeholders.Understanding the Class Action Lawsuit... Continue Reading
Overview of Novavax and Recent DevelopmentsNovavax, Inc. (NASDAQ: NVAX) is currently under investigation due to significant developments that have arisen recently. Recognized for its focus on innovative vaccine development, especially in the context of the COVID-19 pandemic, Novavax has found itself facing scrutiny following critical announcements from the U.S. Food and Drug Administration (FDA). The situation has raised concerns among investors, highlighting the potential impact on ... Continue Reading
Introduction to Biodexa Pharmaceuticals' InvestigationIn recent developments tied to Biodexa Pharmaceuticals Plc (NASDAQ: BDRX), the firm Bronstein, Gewirtz & Grossman, LLC has embarked on an investigation. This scrutiny is aimed at understanding the potential claims on behalf of those who have purchased securities from Biodexa.Overview of Recent Clinical DataOn October 4, 2024, Biodexa announced critical updates regarding its Phase 1 study of the drug MX110, which is... Continue Reading
Elon Musk's Support for Nuclear Energy
Renowned tech entrepreneur Elon Musk has recently expressed strong support for nuclear energy, igniting discussions within the energy sector. At a Town Hall event, he emphasized that the potential dangers of nuclear technology are often exaggerated.
Understanding Modern Nuclear Safety
During the event, Musk highlighted advancements in nuclear reactor technology, claiming, "With the latest technologies, you can a... Continue Reading
Investigation of JFrog Ltd.
Bronstein, Gewirtz & Grossman, LLC is actively looking into claims regarding JFrog Ltd. (NASDAQ: FROG). This comes in light of significant concerns raised by the company’s most recent financial performance and the implications it has for its investors. If you have invested in JFrog securities, it’s essential to stay informed about potential outcomes and your rights as an investor.
Financial Results and Shareholder Impact
Recently, JFrog ann... Continue Reading
Overview of the Investigation into Torrid Holdings Inc.The firm Bronstein, Gewirtz & Grossman, LLC has initiated an investigation concerning Torrid Holdings Inc., also known as Torrid, a company listed on the NYSE as CURV. This investigation follows significant developments related to the company that may have affected its stock performance.Key Events Prompting the InvestigationRecently, Torrid announced the abrupt termination of Elizabeth Muñoz-Guzman, who held the p... Continue Reading
Elanco Animal Health Class Action Lawsuit Opportunity
Attention investors! If you've faced substantial losses in your investments with Elanco Animal Health Incorporated (NYSE: ELAN), this is your chance to take action. Bronstein, Gewirtz & Grossman, LLC, a notable law firm specializing in investor rights, has initiated a class action lawsuit concerning Elanco and some of its key executives.
Understanding the Lawsuit
This class action seeks restitution for those who pu... Continue Reading
Attention Iris Energy Limited Investors
Investors in Iris Energy Limited (NASDAQ: IREN) have an important opportunity to lead a class action lawsuit following significant losses. It has come to light that there are allegations against the company's executives related to misleading statements and potential violations of federal securities laws.
Understanding the Class Action Lawsuit
This legal action is initiated to seek recompense for all individuals and entities that... Continue Reading
Investors Alert: Class Action Lawsuit Against iLearningEngines, Inc.
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit has been initiated against iLearningEngines, Inc. (NASDAQ: AILE) and several of its officers. This alert is crucial for those who have incurred substantial losses as it presents an opportunity to seek recourse through legal means.
Understanding Class Action Lawsuits
A class action lawsuit allows a group of people with similar cla... Continue Reading